BACKGROUND The objective of this retrospective records review was to evaluate the prevalence of metabolic syndrome (MetS) and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics. SUBJECTS AND METHODS Hospital records of 62 patients (27 women and 35 men) taking antipsychotics were retrospectively reviewed for: body height and weight, waist circumference, cigarette s...

OBJECTIVE The International Diabetes Federation (IDF) has recently established a worldwide consensus definition of the metabolic syndrome. No prospective data are available on the cardiovascular risk associated with this new metabolic syndrome definition. RESEARCH DESIGN AND METHODS In a prospective study of 750 coronary patients, we recorded vascular events over 4 years. RESULTS From our p...

Resumo Objetivo Identificar a prevalência da síndrome metabólica e concordância entre os critérios do National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) International Diabetes Federation (IDF) em pessoas vivendo com HIV. Métodos Estudo analítico transversal, realizado cinco serviços especializados município interior paulista, de 2014 2016, 340 Variáveis sociodemográf...

OBJECTIVES We aimed to evaluate eight candidate definitions of the metabolic syndrome (MS) against the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII) definition as the reference for optimally defining MS in adult Asian Indians. RESEARCH DESIGN AND METHODS We used clinical and biochemical data from our previous cross-sectional epidemiological studies. Candidate ...

INTRODUCTION To determine the prevalence of the metabolic syndrome (MS) in an Iranian elderly population and show its association with coronary heart disease (CHD). MATERIALS AND METHODS This is a cross-sectional study on 720 Iranian men and women aged > or = 65 years who participated in the Tehran Lipid and Glucose Study (TLGS). Logistic regression analysis was used to estimate the odds rati...

OBJECTIVE The significance of the metabolic syndrome (MS) is debated. We investigated whether MS component (by ATPIII and IDF definitions) clustering and any association between MS and prevalent cardiovascular disease (CVD) varied with age. RESEARCH DESIGN AND METHODS In all, 1429 adults (≥25 years) from randomly selected households in rural Victoria, Australia, were assessed for components o...

Our paper is a study about metabolism syndrome (MS) incidence situations of different nationalities, including Uighur, Kazak and Han nationality in Xinjiang by means of a cross-sectional survey and compare differences and adaptabilities of applications of the diagnostic criteria for MS recommended by Adult Treatment Protocol III of National Cholesterol Education Program of America (ATP III), In...

OBJECTIVE The prevalence of the metabolic syndrome, a potent risk factor for cardiovascular diseases (CVDs), has not been adequately explored in older individuals. Moreover, two sets of criteria have been proposed for the definition of metabolic syndrome, one by the World Health Organization (WHO) and one by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII). We ...

The metabolic syndrome is a constellation of interrelated abnormalities, including dyslipidemia, elevated blood pressure and glucose, and prothrombotic and proinflammatory states (1). Because of the growing prevalence of the metabolic syndrome, several organizations have attempted to set forth clinical criteria for its diagnosis (1–5). The most recent are those proposed by the International Dia...

AIM We have recently determined the optimal cut-off of the homeostatic model assessment of insulin resistance for the diagnosis of insulin resistance (IR) and metabolic syndrome (MetS) in non-diabetic residents of Tehran, the capital of Iran. The aim of the present study is to establish the optimal cut-off at the national level in the Iranian population with and without diabetes. METHODS Data...